Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

This publication has 33 references indexed in Scilit:

• The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study
  Nephrology Dialysis Transplantation, 2001
• Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
  Kidney International, 2000
• Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy
  Published by Elsevier ,1999
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• Antihypertensive treatment of patients with proteinuric renal diseases: Risks or benefits of calcium channel blockers?
  Kidney International, 1998
• Felodipine
  Drugs, 1992
• Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
  Journal of Clinical Investigation, 1990
• Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
  Journal of Clinical Investigation, 1986
• Repeated assessment of results in clinical trials of cancer treatment
  The British Journal of Radiology, 1971